Breuling Marian, Tomeva Elena, Ivanovic Nevena, Haslberger Alexander
Department of Nutritional Sciences, University of Vienna, A-1090 Vienna, Austria.
HealthBioCare GmbH, A-1090 Vienna, Austria.
Life (Basel). 2024 Jun 21;14(7):787. doi: 10.3390/life14070787.
To examine the butyrate- and beta-hydroxybutyrate (BHB)-modulated effects of pre- and probiotic interventions, fasting, and caloric restriction interventions, a systematic literature review was carried out with a subsequent meta-analysis. Three pre-and probiotic intervention randomized control trials (RCTs) were included in the meta-analysis. A significant increase in butyrate (standardized mean difference (SMD) [confidence interval (CI)] 0.34; [0.02-0.67]) and an improvement in depression scores (SMD [CI] 0.15, [-0.35-0.70]) through pre- and probiotic interventions were shown in the meta-analysis. The intervention duration of the included studies ranged from three days to four weeks, with the examined population being healthy adults. Butyrate was measured in either plasma or feces, and the depression score was obtained under the Swedish core affect scale, the hospital anxiety and depression scale (HADS), or the depression, anxiety, and stress scale-21 items (DASS-21). In addition to butyrate, the total SCFA concentration also seems to be positively associated with pre- and probiotic administration (SMD [CI] 0.55 [0.15-0.95]). Despite the significant short-chain fatty acid (SCFA) and butyrate concentration changes, no significant correlation between butyrate and depression or between SCFAs and depression could be shown through linear regression models. Nevertheless, the regression coefficient b1 = 1.57 ( = 0.17) for butyrate suggests a strong, positive connection between butyrate and depression. Additionally, three studies were qualitatively analyzed, examining fasting as an intervention and revealing a connection between fasting, BHB, and depression. The association between fasting, BHB, and depression or mood elevation appeared to be related to BHB concentrations, which may be due to the similar biochemical properties of BHB and butyrate. Furthermore, caloric restrictions as alternatives to fasting were proposed as potential long-term interventions.
为了研究丁酸和β-羟基丁酸(BHB)对益生元和益生菌干预、禁食和热量限制干预的调节作用,我们进行了一项系统的文献综述,并随后进行了荟萃分析。三项益生元和益生菌干预随机对照试验(RCT)被纳入荟萃分析。荟萃分析显示,通过益生元和益生菌干预,丁酸显著增加(标准化平均差(SMD)[置信区间(CI)]0.34;[0.02 - 0.67]),抑郁评分有所改善(SMD [CI] 0.15,[-0.35 - 0.70])。纳入研究的干预持续时间从三天到四周不等,研究对象为健康成年人。丁酸在血浆或粪便中进行测量,抑郁评分通过瑞典核心情感量表、医院焦虑抑郁量表(HADS)或抑郁、焦虑和压力量表 - 21项(DASS - 21)获得。除了丁酸,总短链脂肪酸(SCFA)浓度似乎也与益生元和益生菌给药呈正相关(SMD [CI] 0.55 [0.15 - 0.95])。尽管短链脂肪酸(SCFA)和丁酸浓度有显著变化,但通过线性回归模型未显示出丁酸与抑郁之间或SCFAs与抑郁之间存在显著相关性。然而,丁酸的回归系数b1 = 1.57( = 0.17)表明丁酸与抑郁之间存在强烈的正相关。此外,对三项研究进行了定性分析,研究了禁食作为一种干预措施,并揭示了禁食、BHB和抑郁之间的联系。禁食、BHB与抑郁或情绪改善之间的关联似乎与BHB浓度有关,这可能是由于BHB和丁酸具有相似的生化特性。此外,提出热量限制作为禁食的替代方法,作为潜在的长期干预措施。